Danielle Martin
Acute Care · Okemos, MINPI 1508369547
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 278 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,335, 2.6 times the $508 reported in 2021. Among acute care clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 278 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$879
- Boehringer Ingelheim$554
- Merck$431
- Bayer$429
- Amgen$412
- Pfizer$233
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,15199%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 61 | $879 |
| Boehringer Ingelheim | 26 | $554 |
| Merck | 22 | $431 |
| Bayer | 25 | $429 |
| Amgen | 22 | $412 |
| Pfizer | 14 | $233 |
| Scpharmaceuticals Inc. | 9 | $193 |
| E.r. Squibb & Sons, L.L.C. | 11 | $185 |
| Alnylam Pharmaceuticals Inc. | 7 | $170 |
| Edwards Lifesciences | 5 | $161 |
| AstraZeneca | 11 | $157 |
| Novo Nordisk | 4 | $113 |
| Sanofi-aventis U.S. LLC | 5 | $112 |
| Irhythm Technologies, Inc. | 4 | $107 |
| Boston Scientific | 4 | $106 |
| Lexicon Pharmaceuticals, Inc. | 3 | $88 |
| Johnson & Johnson | 5 | $84 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $82 |
| Amarin Pharma, Inc. | 4 | $80 |
| Esperion Therapeutics, Inc. | 4 | $79 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $75 |
| Abbott | 3 | $65 |
| Impulse Dynamics (USA) Inc. | 2 | $63 |
| Kowa Pharmaceuticals America, Inc. | 4 | $51 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Baxter Healthcare | 2 | $28 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $24 |
| Angiodynamics, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| GSK | 1 | $21 |
| Vital Connect, Inc | 1 | $21 |
| Medtronic | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $14 |
How this compares
$5,179 in reported general payments places this provider in the 95th percentile of 567 acute care providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 60 | $94,303 |
| EntrestoSacubitril/Valsartan | 35 | $51,484 |
| XareltoRivaroxaban | 23 | $33,183 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 39 | $1,885 |
| Metoprolol Succinate | 106 | $1,720 |
| Losartan Potassium | 73 | $1,201 |
| Atorvastatin Calcium | 67 | $1,186 |
| Rosuvastatin Calcium | 59 | $1,170 |
| Carvedilol | 84 | $1,004 |
| Prasugrel Hcl | 11 | $744 |
| Ezetimibe | 18 | $611 |
| ClopidogrelClopidogrel Bisulfate | 26 | $579 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 23 | $438 |
| Amlodipine Besylate | 62 | $414 |
| Potassium Chloride | 24 | $402 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $233 | $94,30360 claims |
| NovartisEntresto | $879 | $51,48435 claims |
| Johnson & JohnsonXarelto | $84 | $33,18323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 567 acute care providers in Michigan.
Other acute care in Okemos
- Janet WymanDetroit$103K
- Stephanie Mellon ReppenDetroit$57K
- Ashley WozniakLivonia$26K
- Julia BriggsBirch Run$16K
- Candise LovePort Huron$14K
- Janette GuertinPort Huron$14K
- Gregory AliNovi$13K
- Andrew PalmerLansing$9K
- Angela BrennanDearborn Heights$7K
- Jennifer RutzenLansing$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.